Dimerization: |
HOMODIMER INFORMATION |
There is experimental evidence for homo-dimerization
|
METHOD |
Bioluminescence Resonance Energy Transfer (BRET)
|
REFERENCES |
10725388 | 12140284
|
HOMODIMER INFORMATION |
There is experimental evidence for homo-dimerization
|
METHOD |
Immunoprecipitation
|
REFERENCES |
10725388 | 8663163
|
HETERODIMER INFORMATION |
Forms heterodimers with delta Opioid Receptors. Heterodimerization results in altered internalization and MAPK signalling
|
METHOD |
Immunoprecipitation, Bioluminescence Resonance Energy Transfer (BRET), Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET)
|
REFERENCES |
11134510 | 11278447
|
HETERODIMER INFORMATION |
Forms heterodimers with kappa Opioid Receptors. Heterodimerization results in altered internalization and MAPK signalling
|
METHOD |
Immunoprecipitation
|
REFERENCES |
11134510
|
HETERODIMER INFORMATION |
Forms heterodimers with B1 Adrenoceptors. Dimerization results in inhibiting internalization and ERK activation by B2 Adrenoceptor
|
METHOD |
Bioluminescence Resonance Energy Transfer (BRET)
|
REFERENCES |
12244098
|
HETERODIMER INFORMATION |
Forms heterodimers with B1 Adrenoceptors. Dimerization results in inhibiting internalization and ERK activation by B2 Adrenoceptor
|
METHOD |
Immunoprecipitation
|
REFERENCES |
12140284
|